MIVENION GMBH has a total of 36 patent applications. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office), Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and organic fine chemistry are SCHENTAG JEROME J, SINCLAIR PHARMACEUTICALS LTD and PARADIGM BIOPHARMACEUTICALS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | Canada | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | China | 3 | |
#5 | Israel | 3 | |
#6 | New Zealand | 3 | |
#7 | United States | 3 | |
#8 | Brazil | 2 | |
#9 | Australia | 1 | |
#10 | EAPO (Eurasian Patent Organization) | 1 | |
#11 | Republic of Korea | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Organic fine chemistry | |
#4 | Macromolecular chemistry and polymers |
# | Name | Total Patents |
---|---|---|
#1 | Bahner Malte | 20 |
#2 | Haag Rainer | 8 |
#3 | Licha Kai | 8 |
#4 | Schirner Michael | 8 |
#5 | Wiebelitz Ulrike | 7 |
#6 | Heek Timm | 5 |
#7 | Wyszogrodzka Monika | 4 |
#8 | Paulus Florian | 3 |
#9 | Welker Pia | 3 |
#10 | Weinhart Marie | 3 |
Publication | Filing date | Title |
---|---|---|
IL221279D0 | Polyanionic multivalent macromolecules for intracellular targeting of proliferation and porotein synthesis | |
CN102781478A | Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis | |
NZ583011A | Device and procedure for the diagnosis or diagnostic preparation and/or therapy monitoring of inflammatory diseases such as rheumatoid arthritis | |
EP2647392A2 | Imaging diagnostics by combining contrast agents | |
EP2100621A1 | Polyether polyol dendron conjugates with effector molecules for biological targeting | |
EP2036577A1 | Diagnostic materials for optical image-forming investigation based on nanoparticulate formulations |